Anavex Life Sciences Corp (AVXL)

[Anshu2]

Thats exactly I was thinking -- that a large fraction of big money is betting on AVXL (at this point) for its Rhett drug being commercialized soon. Any delay on that front is going to be have a big negative reaction. Perhaps, the sell-off was a combination of Rhett-1Q-delay, Biogen's death, AD-readout jitters-and-FUD.

That's my best guess.

I still am mystified why AVXL has delayed TLR till now .... this can only mean "mixed" results, in my disappointed imagination.